Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Apply zero based budgeting to household expenses to ensure every dollar is assigned, reducing waste and boosting savings.
18,110 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
As SpaceX gears up for a potential IPO, spacex’s lead underwriters have produced a dramatic split in value views, cre...
Today brought a notable move for fintech investors as fiserv stock topped market headlines. Here’s what sparked the r...
AI relies on chips to power today’s breakthroughs. This article uncovers a less-prominent semiconductor ETF idea, why...
Palantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...
Rate expands its mortgage team by bringing 14 loan officers from New American Funding, aiming to boost production and...
This analysis dives into the early 2026 earnings picture for J.Jill, unpacking revenue drivers, margin dynamics, and ...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Intel prepares for a pivotal investor update, and investors want to know whether buying now makes sense. This guide b...
IBM’s profit warning sharpens focus on the Dow’s direction, while technology stocks push Nasdaq higher. Here’s what t...
A Workday insider recently sold a sizable block of shares. This article breaks down what that signals for investors, ...